Published in Drug Law Weekly, January 16th, 2007
The issue of new shares to GSK consists of a private placement by Genmab to Glaxo Group Limited, a private limited company registered under the laws of England, of 4,471,202 new ordinary bearer shares of nominal value DKK 1 (one) each.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.